Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 11

2022 June-1 - 247 articles

Cover Story: Tumor necrosis factor (TNF) receptor-2 (TNFR2) is stimulated by the transmembrane form of TNF and has complex immune regulatory activities. In view of the relevance of the immune system for tumor biology, it is no surprise that TNFR2 affects tumor development in several ways. For example, TNFR2 promotes tumor immune escape by stimulation of immune suppressive cells, e.g. regulatory T-cells (Tregs) and myeloid-derived suppressor cells (MDSCs), but it can also act directly as an oncogene. However, TNFR2 also elicits antitumoral activities by co-stimulation of cytotoxic T cells. In fact, both antagonists and agonists of TNFR2 have been successfully evaluated in preclinical studies for tumor therapy. In this report, we review the most important TNFR2-related findings regarding tumor biology and cancer therapy and discuss the mode of action of currently used agonists and antagonists of TNFR2. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (247)

  • Article
  • Open Access
7 Citations
3,503 Views
14 Pages

Simultaneous and Spatially-Resolved Analysis of T-Lymphocytes, Macrophages and PD-L1 Immune Checkpoint in Rare Cancers

  • Karina Cereceda,
  • Nicolas Bravo,
  • Roddy Jorquera,
  • Roxana González-Stegmaier and
  • Franz Villarroel-Espíndola

6 June 2022

Penile, vulvar and anal neoplasms show an incidence lower than 0.5% of the population per year and therefore can be considered as rare cancers but with a dramatic impact on quality of life and survival. This work describes the experience of a Chilean...

(This article belongs to the Collection Imaging Biomarker in Oncology)
  • Article
  • Open Access
2 Citations
4,195 Views
15 Pages

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

  • David Martínez-Cuadrón,
  • Josefina Serrano,
  • José Mariz,
  • Cristina Gil and ,
  • Mar Tormo,
  • Pilar Martínez-Sánchez,
  • Eduardo Rodríguez-Arbolí,
  • Raimundo García-Boyero,
  • Carlos Rodríguez-Medina and
  • on behalf of the PETHEMA Group
  • + 34 authors+ 29 authors

6 June 2022

This retrospective study investigated outcomes of 404 patients with relapsed/refractory (R/R) FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) acute myeloid leukemia (AML) enrolled in the PETHEMA registry, pre-approval of tyrosine...

(This article belongs to the Collection Acute Myeloid Leukemia (AML))
  • Article
  • Open Access
14 Citations
5,592 Views
16 Pages

6 June 2022

Efficient predictive biomarkers are urgently needed to identify non-small cell lung cancer (NSCLC) patients who could benefit from immune checkpoint blockade (ICB) therapy. Since chromatin remodeling is required for DNA repair process, we asked wheth...

(This article belongs to the Special Issue Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA))
  • Systematic Review
  • Open Access
10 Citations
5,568 Views
16 Pages

Novel Pharmacological Treatment Options in Pediatric Glioblastoma—A Systematic Review

  • Johanna Wyss,
  • Nicole Alexandra Frank,
  • Jehuda Soleman and
  • Katrin Scheinemann

6 June 2022

Background: Pediatric glioblastoma (GBM) is an aggressive central nervous system tumor in children that has dismal prognosis. Standard of care is surgery with subsequent irradiation and temozolomide. We aimed to outline currently available data on no...

(This article belongs to the Special Issue Recent Advances in Drug Therapy for Glioblastoma)
  • Communication
  • Open Access
3 Citations
3,524 Views
12 Pages

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

  • Kai-Jie Yu,
  • De-Yi Ji,
  • Ming-Li Hsieh,
  • Cheng-Keng Chuang and ,
  • See-Tong Pang and
  • Wen-Hui Weng
  • + 1 author+ 0 author

6 June 2022

It is known that miRNA-378a-3p (miR-378) could be induced by eicosapentaenoic acid (EPA), an omega-3 fatty acid. Herein, we first demonstrated how miR-378 exerts anti-prostate cancer (PCa) actions by influencing multiple target genes, including KLK2,...

(This article belongs to the Special Issue Actual Aspects of Prostate Cancer Treatment—an Interdisciplinary Approach)
  • Article
  • Open Access
62 Citations
5,198 Views
13 Pages

Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes

  • Katherine E. Richards,
  • Weikun Xiao,
  • Reginald Hill and
  • on behalf of the USC Pancreas Research Team

6 June 2022

Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer-related death in the United States. Even though the poor prognosis of PDAC is often attributed to late diagnosis, patients with an early diagnosis who undergo tumo...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
9 Citations
4,646 Views
19 Pages

Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation

  • Ram Babu Undi,
  • Adrian Filiberti,
  • Naushad Ali and
  • Mark M. Huycke

6 June 2022

Inflammation is an essential hallmark of cancer. Macrophages are key innate immune effector cells in chronic inflammation, parainflammation, and inflammaging. Parainflammation is a form of subclinical inflammation associated with a persistent DNA dam...

(This article belongs to the Special Issue Tumor, Tumor-Associated Macrophages, and Therapy)
  • Article
  • Open Access
9 Citations
4,014 Views
13 Pages

Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers

  • Stephanie Staudte,
  • Konrad Klinghammer,
  • Philipp Sebastian Jurmeister,
  • Paul Jank and ,
  • Jens-Uwe Blohmer,
  • Sandra Liebs,
  • Peter Rhein,
  • Anja E. Hauser and
  • Ingeborg Tinhofer
  • + 4 authors+ 0 author

6 June 2022

Detection of circulating tumor cells (CTCs) has been established as an independent prognostic marker in solid cancer. Multiparametric phenotyping of CTCs could expand the area of application for this liquid biomarker. We evaluated the Amnis® bran...

(This article belongs to the Special Issue Circulating Tumor Cells: From the Laboratory to the Cancer Clinic)
  • Review
  • Open Access
28 Citations
6,292 Views
16 Pages

Management of Older Adults with Locally Advanced Head and Neck Cancer

  • Daniel R. Dickstein,
  • Eric J. Lehrer,
  • Kristin Hsieh,
  • Alexandra Hotca and ,
  • Brianna M. Jones,
  • Ann Powers,
  • Sonam Sharma,
  • Jerry Liu,
  • Vishal Gupta and
  • Richard L. Bakst
  • + 11 authors+ 6 authors

5 June 2022

Thirty percent of patients with head and neck squamous cell carcinoma (HNSCC) are at least 70 years of age. This number continues to rise as life expectancy continues to increase. Still, older adults with HNSCC remain underrepresented in clinical tri...

  • Article
  • Open Access
11 Citations
4,467 Views
20 Pages

5 June 2022

Exercise is known to help the immune function of cancer survivors after cancer cell removal, but there is little information about the effect of exercise on ovarian cancer survivors. We conducted this study to investigate the effects of exercise trai...

(This article belongs to the Special Issue Lifestyle Modifications and Survival of Cancer Patients)
  • Article
  • Open Access
14 Citations
4,978 Views
24 Pages

SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways

  • Ariana Acevedo-Díaz,
  • Beatriz M. Morales-Cabán,
  • Astrid Zayas-Santiago,
  • Michelle M. Martínez-Montemayor and
  • Ivette J. Suárez-Arroyo

5 June 2022

Triple-negative breast cancer (TNBC) is the most aggressive, metastatic, and lethal breast cancer subtype. To improve the survival of TNBC patients, it is essential to explore new signaling pathways for the further development of effective drugs. Thi...

  • Review
  • Open Access
30 Citations
9,340 Views
24 Pages

5 June 2022

Acute myeloid leukemia (AML) is a genetically heterogeneous hematological malignancy. Chromosomal and genetic analyses are important for the diagnosis and prognosis of AML. Some patients experience relapse or have refractory disease, despite conventi...

(This article belongs to the Special Issue New Therapeutic Strategies for Acute Myeloid Leukemia)
  • Article
  • Open Access
5 Citations
4,065 Views
28 Pages

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels

  • Xiaozeng Lin,
  • Yan Gu,
  • Yingying Su,
  • Ying Dong and ,
  • Pierre Major,
  • Anil Kapoor and
  • Damu Tang
  • + 2 authors+ 0 author

5 June 2022

Effective assessment of adrenocortical carcinoma (ACC) prognosis is critical in patient management. We report four novel and robust prognostic multigene panels. Sig27var25, SigIQvar8, SigCmbnvar5, and SigCmbn_B predict ACC relapse at area under the c...

(This article belongs to the Special Issue Innovations in Cancer Diagnostic Evaluation and Biomarker Detection)
  • Review
  • Open Access
21 Citations
6,780 Views
18 Pages

5 June 2022

PARP1 enzyme plays an important role in DNA damage recognition and signalling. PARP inhibitors are approved in breast, ovarian, pancreatic, and prostate cancers harbouring a pathogenic variant in BRCA1 or BRCA2, where PARP1 inhibition results mainly...

(This article belongs to the Special Issue A Deeper Dive into Signaling Pathways in Cancers)
  • Article
  • Open Access
5 Citations
3,780 Views
7 Pages

Interobserver Reliability and the Sigmoid Takeoff—An Interobserver Study

  • Malene Roland Vils Pedersen,
  • Peter Obel Otto,
  • Chris Vagn-Hansen,
  • Torben Sørensen and
  • Søren Rafael Rafaelsen

4 June 2022

Background: Colorectal cancer is the second most common cancer worldwide. The sigmoid takeoff is the landmark where the colon sigmoid curves toward the sacrum viewed from sagittal magnetic resonance imaging (MRI). The purpose of this study was to ass...

(This article belongs to the Special Issue A Model for Improved Care of Patients with Colorectal Cancer – Experience from a Center of Clinical Excellence)
  • Article
  • Open Access
8 Citations
3,667 Views
11 Pages

Glioblastoma Stem-like Cell Detection Using Perfusion and Diffusion MRI

  • Tanguy Duval,
  • Jean-Albert Lotterie,
  • Anthony Lemarie,
  • Caroline Delmas and ,
  • Fatima Tensaouti,
  • Elizabeth Cohen-Jonathan Moyal and
  • Vincent Lubrano
  • + 2 authors+ 0 author

4 June 2022

Purpose: With current gold standard treatment, which associates maximum safe surgery and chemo-radiation, the large majority of glioblastoma patients relapse within a year in the peritumoral non contrast-enhanced region (NCE). A subpopulation of glio...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
3,347 Views
11 Pages

In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case Series

  • Saira Sanjida,
  • Brigid Betz-Stablein,
  • Victoria Atkinson,
  • Monika Janda and ,
  • Ramez Barsoum,
  • Harrison Aljian Edwards,
  • Frank Chiu,
  • My Co Tran,
  • H Peter Soyer and
  • Helmut Schaider
  • + 5 authors+ 0 author

4 June 2022

Immunotherapies and targeted therapies have shown significant benefits for melanoma survival in the clinical trial setting. Much less is known about the characteristics and associated outcomes of those receiving such therapies in real-world settings....

(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Skin Cancer)
  • Article
  • Open Access
12 Citations
5,158 Views
30 Pages

Integrated Multi-Omics Maps of Lower-Grade Gliomas

  • Hans Binder,
  • Maria Schmidt,
  • Lydia Hopp,
  • Suren Davitavyan and ,
  • Arsen Arakelyan and
  • Henry Loeffler-Wirth
  • + 1 author+ 0 author

4 June 2022

Multi-omics high-throughput technologies produce data sets which are not restricted to only one but consist of multiple omics modalities, often as patient-matched tumour specimens. The integrative analysis of these omics modalities is essential to ob...

(This article belongs to the Special Issue Multi-Omics Approaches in Oncology)
  • Article
  • Open Access
4 Citations
3,927 Views
20 Pages

Process Evaluation of a Sport-Based Supportive Care Intervention for Testicular Cancer Survivors: A Mixed Methods Study

  • Anika R. Petrella,
  • Catherine M. Sabiston,
  • Roxy H. O’Rourke,
  • Daniel Santa Mina and ,
  • Robert J. Hamilton and
  • Andrew G. Matthew
  • + 1 author+ 0 author

4 June 2022

Testicular cancer survivors report unmet supportive care needs that are associated with poorer physical and mental health, yet engagement in traditional supportive care is low. The Ball’s in Your Court intervention was designed to engage testic...

(This article belongs to the Special Issue Recent Advances in Pediatric, Adolescent and Young Adult (AYA) Psycho-Oncology)
  • Review
  • Open Access
11 Citations
5,613 Views
21 Pages

The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas

  • Mutaz Jamal Al-Khreisat,
  • Faezahtul Arbaeyah Hussain,
  • Ali Mahmoud Abdelfattah,
  • Alhomidi Almotiri and ,
  • Ola Mohammed Al-Sanabra and
  • Muhammad Farid Johan
  • + 1 author+ 0 author

4 June 2022

Lymphomas are heterogeneous malignant tumours of white blood cells characterised by the aberrant proliferation of mature lymphoid cells or their precursors. Lymphomas are classified into main types depending on the histopathologic evidence of biopsy...

(This article belongs to the Special Issue Peripheral T-cell Lymphoma: From Biological Research to New Therapies)
  • Article
  • Open Access
7 Citations
3,670 Views
17 Pages

LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications

  • Junlong Wang,
  • Dionyssios Katsaros,
  • Nicoletta Biglia,
  • Yuanyuan Fu and ,
  • Chiara Benedetto,
  • Lenora Loo,
  • Zhanwei Wang and
  • Herbert Yu
  • + 3 authors+ 0 author

4 June 2022

Background: Long non-coding RNAs (lncRNAs) play an important role in cellular activities and functions, but our understanding of their involvement in cancer is limited. Methods: TCGA data on RNA expression and DNA methylation were analyzed for lncRNA...

(This article belongs to the Special Issue Targeting the Vulnerabilities of Oncogene Activation)
  • Article
  • Open Access
7 Citations
3,839 Views
15 Pages

High Levels of MFG-E8 Confer a Good Prognosis in Prostate and Renal Cancer Patients

  • Karen Geoffroy,
  • Patrick Laplante,
  • Sylvie Clairefond,
  • Feryel Azzi and ,
  • Dominique Trudel,
  • Jean-Baptiste Lattouf,
  • John Stagg,
  • Fred Saad,
  • Anne-Marie Mes-Masson and
  • Jean-François Cailhier
  • + 6 authors+ 1 author

4 June 2022

Milk fat globule-epidermal growth factor-8 (MFG-E8) is a glycoprotein secreted by different cell types, including apoptotic cells and activated macrophages. MFG-E8 is highly expressed in a variety of cancers and is classically associated with tumor g...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
316 Citations
22,466 Views
23 Pages

Emerging Therapies for Hepatocellular Carcinoma (HCC)

  • Eesha Chakraborty and
  • Devanand Sarkar

4 June 2022

Hepatocellular carcinoma (HCC) arises from hepatocytes and accounts for 90% of primary liver cancer. According to Global Cancer Incidence, Mortality and Prevalence (GLOBOCAN) 2020, globally HCC is the sixth most common cancer and the third most commo...

(This article belongs to the Collection Advances in the Management of Hepatocellular Carcinoma)
  • Article
  • Open Access
19 Citations
5,123 Views
20 Pages

Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer

  • Adam L. Maddox,
  • Matthew S. Brehove,
  • Kiarash R. Eliato,
  • Andras Saftics and ,
  • Eugenia Romano,
  • Michael F. Press,
  • Joanne Mortimer,
  • Veronica Jones,
  • Daniel Schmolze and
  • Tijana Jovanovic-Talisman
  • + 6 authors+ 1 author

4 June 2022

Trastuzumab, the prototype HER2-directed therapy, has markedly improved survival for women with HER2-positive breast cancers. However, only 40–60% of women with HER2-positive breast cancers achieve a complete pathological response to chemothera...

  • Article
  • Open Access
9 Citations
3,501 Views
10 Pages

SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition

  • Evangelos Terpos,
  • Michalis Liontos,
  • Oraianthi Fiste,
  • Flora Zagouri and ,
  • Alexandros Briasoulis,
  • Aimilia D. Sklirou,
  • Christos Markellos,
  • Efthymia Skafida,
  • Alkistis Papatheodoridi and
  • Meletios-Athanasios Dimopoulos
  • + 10 authors+ 5 authors

4 June 2022

Considering that COVID-19 could adversely affect cancer patients, several countries have prioritized this highly susceptible population for vaccination. Thus, rapidly generating evidence on the efficacy of SARS-CoV-2 vaccination in the subset of pati...

  • Article
  • Open Access
14 Citations
4,907 Views
19 Pages

4 June 2022

At least one member of the Guanylate-Binding Protein (GBP) family of large interferon-induced GTPases has been classified as both a marker of good prognosis and as a potential drug target to treat breast cancers. However, the activity of individual G...

(This article belongs to the Special Issue Triple Negative Breast Cancer: From Biology to Treatment)
  • Article
  • Open Access
7 Citations
3,533 Views
20 Pages

Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers

  • Adriana Ionescu,
  • Liviu Bilteanu,
  • Ovidiu Ionut Geicu,
  • Florin Iordache and ,
  • Loredana Stanca,
  • Aurelia Magdalena Pisoschi,
  • Adrian Miron,
  • Andreea Iren Serban and
  • Valentin Calu
  • + 4 authors+ 0 author

4 June 2022

Background: Biomarker profiles should represent a coherent description of the colorectal cancer (CRC) stage and its predicted evolution. Methods: Using droplet digital PCR, we detected the allelic frequencies (AF) of KRAS, NRAS, BRAF, and EGFR mutati...

  • Review
  • Open Access
68 Citations
9,814 Views
15 Pages

The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated

  • Roumaïssa Gouasmi,
  • Carole Ferraro-Peyret,
  • Stéphane Nancey,
  • Isabelle Coste and ,
  • Toufic Renno,
  • Cédric Chaveroux,
  • Nicolas Aznar and
  • Stéphane Ansieau
  • + 3 authors+ 0 author

4 June 2022

The kynurenine pathway has been highlighted as a gatekeeper of immune-privileged sites through its ability to generate from tryptophan a set of immunosuppressive metabolic intermediates. It additionally constitutes an important source of cellular NAD...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
16 Citations
5,948 Views
14 Pages

Proton Therapy in the Management of Pancreatic Cancer

  • Jana M. Kobeissi,
  • Charles B. Simone,
  • Haibo Lin,
  • Lara Hilal and
  • Carla Hajj

4 June 2022

Radiation therapy plays a central role in the treatment of pancreatic cancer. While generally shown to be feasible, proton irradiation, particularly when an ablative dose is planned, remains a challenge, especially due to tumor motion and the proximi...

(This article belongs to the Special Issue Application of Proton Beam Therapy in Cancer Treatment)
  • Article
  • Open Access
15 Citations
3,626 Views
11 Pages

Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?

  • Heithem Jeddou,
  • Stylianos Tzedakis,
  • Francesco Orlando,
  • Antoine Robert and ,
  • Eric Meneyrol,
  • Damien Bergeat,
  • Fabien Robin,
  • Laurent Sulpice and
  • Karim Boudjema
  • + 4 authors+ 0 author

4 June 2022

How the side of an extended liver resection impacts the postoperative prognosis of advanced perihilar cholangiocarcinoma (PHC) is still controversial. We compared the outcomes of right (RTS) and left trisectionectomies (LTS) in Bismuth-Corlette (BC)...

  • Article
  • Open Access
15 Citations
5,100 Views
20 Pages

Synthetic 18F-FDG PET Image Generation Using a Combination of Biomathematical Modeling and Machine Learning

  • Mohammad Amin Abazari,
  • Madjid Soltani,
  • Farshad Moradi Kashkooli and
  • Kaamran Raahemifar

3 June 2022

No previous works have attempted to combine generative adversarial network (GAN) architectures and the biomathematical modeling of positron emission tomography (PET) radiotracer uptake in tumors to generate extra training samples. Here, we developed...

(This article belongs to the Collection Artificial Intelligence in Oncology)
  • Article
  • Open Access
22 Citations
5,463 Views
19 Pages

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001

  • Vilde Yuli Stenberg,
  • Anna Julie Kjøl Tornes,
  • Hogne Røed Nilsen,
  • Mona-Elisabeth Revheim and ,
  • Øyvind Sverre Bruland,
  • Roy Hartvig Larsen and
  • Asta Juzeniene
  • + 2 authors+ 0 author

3 June 2022

This study aimed to determine the influence of cellular PSMA expression, radioligand binding and internalization, and repeated administrations on the therapeutic effects of the PSMA-targeting radioligand 212Pb-NG001. Cellular binding and internalizat...

(This article belongs to the Special Issue Prostate Cancer Therapy)
  • Systematic Review
  • Open Access
18 Citations
5,846 Views
13 Pages

Hobnail Papillary Thyroid Carcinoma, A Systematic Review and Meta-Analysis

  • Ariadni Spyroglou,
  • Georgios Kostopoulos,
  • Sofia Tseleni,
  • Konstantinos Toulis and ,
  • Konstantinos Bramis,
  • George Mastorakos,
  • Manousos Konstadoulakis,
  • Kyriakos Vamvakidis and
  • Krystallenia I. Alexandraki
  • + 4 authors+ 0 author

3 June 2022

Although papillary thyroid carcinoma (PTC) is considered to have an excellent prognosis, some recently identified more aggressive variants show reduced overall survival rates. Hobnail PTC (HPTC) was newly recognized as one of these aggressive forms,...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
31 Citations
6,657 Views
19 Pages

3 June 2022

The importance of non-coding RNAs for regulating gene expression has been uncovered in model systems spanning all three domains of life. More recently, their involvement in modulating signal transduction, cell proliferation, tumorigenesis and cancer...

(This article belongs to the Collection The Role of Non-coding RNA in Cancer)
  • Article
  • Open Access
2,559 Views
14 Pages

Spline Analysis of Biomarker Data Pooled from Multiple Matched/Nested Case–Control Studies

  • Yujie Wu,
  • Mitchell Gail,
  • Stephanie Smith-Warner,
  • Regina Ziegler and
  • Molin Wang

3 June 2022

Pooling biomarker data across multiple studies enables researchers to obtain precise estimates of the association between biomarker measurements and disease risks due to increased sample sizes. However, biomarker measurements often vary significantly...

(This article belongs to the Special Issue The Application of Biostatistics in Cancers)
  • Article
  • Open Access
20 Citations
5,799 Views
18 Pages

KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer

  • Avery T. Funkhouser,
  • Alexander M. Strigenz,
  • Bailey B. Blair,
  • Andrew P. Miller and ,
  • Jonah C. Shealy,
  • Joseph A. Ewing,
  • Julie C. Martin,
  • Christopher R. Funk,
  • William J. Edenfield and
  • Anna V. Blenda
  • + 5 authors+ 0 author

3 June 2022

To investigate a potential role for galectins as biomarkers that enable diagnosis or prognostication of breast or non-small cell lung cancer, the serum levels of galectins -1, -3, -7, -8, and -9 of cancer patients determined by ELISA assays were comp...

(This article belongs to the Special Issue Inside Cancer Genomics: From Structure to Therapy)
  • Review
  • Open Access
38 Citations
7,827 Views
13 Pages

Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)

  • Giorgia Mangili,
  • Giulia Sabetta,
  • Raffaella Cioffi,
  • Emanuela Rabaiotti and ,
  • Giorgio Candotti,
  • Francesca Pella,
  • Massimo Candiani and
  • Alice Bergamini
  • + 3 authors+ 0 author

3 June 2022

Background: Gestational trophoblastic disease includes a rare group of benign and malignant tumors derived from abnormal trophoblastic proliferation. Malignant forms are called gestational trophoblastic neoplasia (GTN) and include invasive mole, chor...

  • Review
  • Open Access
13 Citations
3,322 Views
10 Pages

3 June 2022

Different from normal cells, cancer cells must hyperactivate a variety of integrated responses in order to survive their basal stress or its exacerbation caused by exposure to anti-cancer agents. As cancer cells become particularly dependent on these...

(This article belongs to the Special Issue Advances in Immuno-Oncology Research)
  • Article
  • Open Access
22 Citations
3,993 Views
13 Pages

Parental Sleep, Distress, and Quality of Life in Childhood Acute Lymphoblastic Leukemia: A Longitudinal Report from Diagnosis up to Three Years Later

  • Niki Rensen,
  • Lindsay Steur,
  • Martha Grootenhuis,
  • Jos Twisk and ,
  • Natasha van Eijkelenburg,
  • Inge van der Sluis,
  • Natasja Dors,
  • Cor van den Bos,
  • Wim Tissing and
  • Raphaële van Litsenburg
  • + 6 authors+ 1 author

3 June 2022

This study assessed sleep, distress and quality of life (QoL) in parents of children with acute lymphoblastic leukemia (ALL) from diagnosis to three years after, and the impact of sleep and distress on QoL. Additionally, this study explored determina...

(This article belongs to the Special Issue Recent Advances in Pediatric, Adolescent and Young Adult (AYA) Psycho-Oncology)
  • Review
  • Open Access
14 Citations
12,330 Views
14 Pages

Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles

  • Izabela Łasińska,
  • Aleksandra Zielińska,
  • Jacek Mackiewicz and
  • Eliana B. Souto

3 June 2022

Skin cancer is the most common type of carcinoma diagnosed worldwide, with significant morbidity and mortality rates among Caucasians, in particular basal cell carcinoma (BCC). The main risk factors of BCC are well-identified, and there are many chem...

  • Article
  • Open Access
14 Citations
3,999 Views
14 Pages

Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0

  • Savio G. Barreto,
  • Simone I. Strasser,
  • Geoffrey W. McCaughan,
  • Michael A. Fink and ,
  • Robert Jones,
  • John McCall,
  • Stephen Munn,
  • Graeme A. Macdonald,
  • Peter Hodgkinson and
  • John W. Chen
  • + 9 authors+ 4 authors

3 June 2022

Background: Expansion in liver transplantation (LT) criteria for HCC from Milan to UCSF has not adversely impacted overall survival, prompting further expansion towards Metroticket 2.0 (MT2). In this study, we compared patient survival post-transplan...

(This article belongs to the Special Issue Clinical and Translational Research in Gastrointestinal Cancers)
  • Article
  • Open Access
10 Citations
4,118 Views
8 Pages

Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future

  • Karla Alfaro,
  • Montserrat Soler,
  • Mauricio Maza,
  • Mauricio Flores and ,
  • Leticia López,
  • Juan C. Rauda,
  • Andrea Chacón,
  • Patricia Erazo,
  • Nora Villatoro and
  • Miriam Cremer
  • + 9 authors+ 4 authors

3 June 2022

Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases a...

(This article belongs to the Special Issue Successes and Barriers of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination)
  • Review
  • Open Access
16 Citations
8,199 Views
22 Pages

Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors

  • Frank Rojas,
  • Edwin Roger Parra,
  • Ignacio Ivan Wistuba,
  • Cara Haymaker and
  • Luisa Maren Solis Soto

2 June 2022

Lung cancer is the leading cause of cancer incidence and mortality worldwide. Adjuvant and neoadjuvant chemotherapy have been used in the perioperative setting of non-small-cell carcinoma (NSCLC); however, the five-year survival rate only improves by...

(This article belongs to the Special Issue Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. A Selection of Papers from the Third Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA))
  • Article
  • Open Access
11 Citations
3,552 Views
10 Pages

Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience

  • Fanny Cahn,
  • Gabriel Revon-Riviere,
  • Victoria Min,
  • Angélique Rome and ,
  • Pauline Filaine,
  • Annick Pelletier,
  • Sylvie Abed,
  • Jean-Claude Gentet,
  • Arnauld Verschuur and
  • Nicolas André
  • + 5 authors+ 0 author

2 June 2022

Precision oncology requires tumor molecular profiling to identify actionable targets. Tumor biopsies are considered as the gold standard, but their indications are limited by the burden of procedures in children. Blood-derived liquid biopsy (LB) is a...

(This article belongs to the Special Issue Targeted Therapies for Pediatric Solid Tumors)
  • Article
  • Open Access
9 Citations
3,467 Views
12 Pages

Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment

  • Susanne Ghandili,
  • Philipp H. von Kroge,
  • Marcel Simon,
  • Frank O. Henes and ,
  • Holger Rohde,
  • Armin Hoffmann,
  • Nick Benjamin Lindeman,
  • Carsten Bokemeyer,
  • Walter Fiedler and
  • Franziska Modemann
  • + 5 authors+ 0 author

2 June 2022

Despite therapeutic advances in the prevention and treatment of febrile neutropenia, acute leukemia (AL) patients still have considerable febrile neutropenia-related mortality. However, the diagnostic yield of flexible bronchoscopy (FB) and bronchoal...

(This article belongs to the Section Infectious Agents and Cancer)
  • Article
  • Open Access
16 Citations
3,217 Views
14 Pages

Long-Term Exposure to Decabromodiphenyl Ether Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by Inhibiting TRß

  • Xinpei Wang,
  • Xiujie Cui,
  • Qian Zhao,
  • Feifei Sun and ,
  • Ru Zhao,
  • Tingting Feng,
  • Shaofeng Sui,
  • Bo Han and
  • Zhiyan Liu
  • + 4 authors+ 0 author

2 June 2022

Polybrominated diphenyl ethers (PBDEs) have been reported to possess endocrine-disrupting and tumour-promoting activity. However, the effects of long-term exposure to decabromodiphenyl ether (BDE209) on thyroid tumourigenesis of papillary thyroid car...

(This article belongs to the Special Issue Molecular Advances and Targeted Therapy in Asian Thyroid Practice)
  • Article
  • Open Access
16 Citations
3,593 Views
15 Pages

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)

  • Remedios Otero,
  • Aurora Solier-López,
  • Verónica Sánchez-López,
  • Julia Oto and ,
  • Elena Arellano,
  • Samira Marín,
  • Luis Jara-Palomares,
  • Teresa Elías,
  • María Isabel Asencio and
  • Pilar Medina
  • + 11 authors+ 6 authors

2 June 2022

The most appropriate duration of anticoagulant treatment for cancer-associated venous thromboembolism (CAT) remains unclear. We have conducted a prospective multicenter study in CAT patients with more than 6 months of anticoagulant treatment to predi...

  • Article
  • Open Access
13 Citations
4,119 Views
19 Pages

HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy

  • Amanda Rosewell Shaw,
  • Caroline Porter,
  • Greyson Biegert,
  • Lisa Jatta and
  • Masataka Suzuki

2 June 2022

For decades, Adenoviruses (Ads) have been staple cancer gene therapy vectors. Ads are highly immunogenic, making them effective adjuvants. These viruses have well characterized genomes, allowing for substantial modifications including capsid chimeris...

(This article belongs to the Special Issue Oncolytic Viruses as Cancer Immunotherapy Agents)
  • Article
  • Open Access
28 Citations
3,472 Views
18 Pages

Chaotic Sparrow Search Algorithm with Deep Transfer Learning Enabled Breast Cancer Classification on Histopathological Images

  • K. Shankar,
  • Ashit Kumar Dutta,
  • Sachin Kumar,
  • Gyanendra Prasad Joshi and
  • Ill Chul Doo

2 June 2022

Breast cancer is the major cause behind the death of women worldwide and is responsible for several deaths each year. Even though there are several means to identify breast cancer, histopathological diagnosis is now considered the gold standard in th...

(This article belongs to the Special Issue Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment)
  • Article
  • Open Access
8 Citations
4,940 Views
24 Pages

Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations

  • Mitchell Acland,
  • Noor A. Lokman,
  • Clifford Young,
  • Dovile Anderson and ,
  • Mark Condina,
  • Chris Desire,
  • Tannith M. Noye,
  • Wanqi Wang,
  • Carmela Ricciardelli and
  • Manuela Klingler-Hoffmann
  • + 8 authors+ 3 authors

2 June 2022

Chemoresistance remains the major barrier to effective ovarian cancer treatment. The molecular features and associated biological functions of this phenotype remain poorly understood. We developed carboplatin-resistant cell line models using OVCAR5 a...

(This article belongs to the Special Issue Ovarian Cancer Biomarkers, Diagnostic and Therapeutic Technologies)

of 5

XFacebookLinkedIn
Cancers - ISSN 2072-6694